121 related articles for article (PubMed ID: 35798387)
1. Impact of
Ruel NM; Nguyen KH; Kim CS; Andrade LPS; Hammond JR
J Pharmacol Exp Ther; 2022 Sep; 382(3):335-345. PubMed ID: 35798387
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase Transporter.
Ruel NM; Nguyen KH; Vilas G; Hammond JR
Mol Pharmacol; 2019 Jun; 95(6):584-596. PubMed ID: 30910793
[TBL] [Abstract][Full Text] [Related]
3. Functional Analysis of the Role of Equilibrative Nucleobase Transporter 1 (ENBT1/SLC43A3) in Adenine Transport in HepG2 Cells.
Takenaka R; Yasujima T; Furukawa J; Hishikawa Y; Yamashiro T; Ohta K; Inoue K; Yuasa H
J Pharm Sci; 2020 Aug; 109(8):2622-2628. PubMed ID: 32339528
[TBL] [Abstract][Full Text] [Related]
4. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
5. Transport Characteristics of 6-Mercaptopurine in Brain Microvascular Endothelial Cells Derived From Human Induced Pluripotent Stem Cells.
Kurosawa T; Tega Y; Sako D; Mochizuki T; Yamaguchi T; Kawabata K; Inoue K; Ito N; Kusuhara H; Deguchi Y
J Pharm Sci; 2021 Oct; 110(10):3484-3490. PubMed ID: 34102205
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia.
Adamson PC; Poplack DG; Balis FM
Leuk Res; 1994 Nov; 18(11):805-10. PubMed ID: 7967706
[TBL] [Abstract][Full Text] [Related]
7. Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammals.
Furukawa J; Inoue K; Maeda J; Yasujima T; Ohta K; Kanai Y; Takada T; Matsuo H; Yuasa H
Sci Rep; 2015 Oct; 5():15057. PubMed ID: 26455426
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress modulates nucleobase transport in microvascular endothelial cells.
Bone DB; Antic M; Vilas G; Hammond JR
Microvasc Res; 2014 Sep; 95():68-75. PubMed ID: 24976360
[TBL] [Abstract][Full Text] [Related]
9. Model Analysis of the Apparent Saturation Kinetics of Purine Nucleobase Uptake in Cells co-Expressing Transporter and Metabolic Enzyme.
Suzuki S; Inoue K; Tamai I; Shirasaka Y
Pharm Res; 2021 Sep; 38(9):1585-1592. PubMed ID: 34435306
[TBL] [Abstract][Full Text] [Related]
10. An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells.
Oliveira BM; Romanha AJ; Alves TM; Viana MB; Zani CL
Braz J Med Biol Res; 2004 May; 37(5):649-58. PubMed ID: 15107925
[TBL] [Abstract][Full Text] [Related]
11. [Effects of PCI-32765 and Dasatinib on the Acute Lymphoblastic Leukemic Cells and Their Mechanisms].
Deng Y; Tao SD; Zhang X; Ma JJ; He ZM; Chen Y; Deng ZK; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):72-79. PubMed ID: 28245378
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract][Full Text] [Related]
14. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
[TBL] [Abstract][Full Text] [Related]
15. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo.
Dervieux T; Brenner TL; Hon YY; Zhou Y; Hancock ML; Sandlund JT; Rivera GK; Ribeiro RC; Boyett JM; Pui CH; Relling MV; Evans WE
Blood; 2002 Aug; 100(4):1240-7. PubMed ID: 12149204
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia.
Zou Y; Mei D; Yuan J; Han J; Xu J; Sun N; He H; Yang C; Zhao L
Int J Nanomedicine; 2021; 16():1127-1141. PubMed ID: 33603372
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of
Moriyama T; Liu S; Li J; Meyer J; Zhao X; Yang W; Shao Y; Heath R; Hnízda A; Carroll WL; Yang JJ
Mol Cancer Ther; 2019 Oct; 18(10):1887-1895. PubMed ID: 31358663
[TBL] [Abstract][Full Text] [Related]
18. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
19. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation.
Dong N; Ma HX; Liu XQ; Li D; Liu LH; Shi Q; Ju XL
Cell Death Dis; 2024 Mar; 15(3):216. PubMed ID: 38485947
[TBL] [Abstract][Full Text] [Related]
20.
Mender I; Batten K; Peyton M; Vemula A; Cornelius C; Girard L; Gao B; Minna JD; Shay JW
Cancer Res; 2020 Mar; 80(5):929-936. PubMed ID: 31948943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
